nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP2C9—brain cancer	0.505	1	CbGaD
Zolpidem—CYP2D6—Lomustine—brain cancer	0.0531	0.178	CbGbCtD
Zolpidem—CYP1A2—Carmustine—brain cancer	0.0525	0.176	CbGbCtD
Zolpidem—CYP2D6—Hydroxyurea—brain cancer	0.0402	0.135	CbGbCtD
Zolpidem—CYP3A4—Temozolomide—brain cancer	0.0397	0.133	CbGbCtD
Zolpidem—PTGS1—Etoposide—brain cancer	0.0348	0.117	CbGbCtD
Zolpidem—CYP3A4—Lomustine—brain cancer	0.0338	0.113	CbGbCtD
Zolpidem—CYP3A5—Etoposide—brain cancer	0.0209	0.07	CbGbCtD
Zolpidem—CYP1A2—Etoposide—brain cancer	0.0156	0.0521	CbGbCtD
Zolpidem—CYP3A4—Etoposide—brain cancer	0.00816	0.0273	CbGbCtD
Zolpidem—GABRA2—ganglion—brain cancer	0.00168	0.0474	CbGeAlD
Zolpidem—GABRB2—hindbrain—brain cancer	0.00139	0.0393	CbGeAlD
Zolpidem—GABRA2—hindbrain—brain cancer	0.00127	0.0359	CbGeAlD
Zolpidem—GABRA1—hindbrain—brain cancer	0.00123	0.0347	CbGeAlD
Zolpidem—PTGS1—ganglion—brain cancer	0.000863	0.0244	CbGeAlD
Zolpidem—GABRB2—brainstem—brain cancer	0.000797	0.0225	CbGeAlD
Zolpidem—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000765	0.0416	CbGpPWpGaD
Zolpidem—PTGS1—endothelium—brain cancer	0.000744	0.021	CbGeAlD
Zolpidem—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000729	0.0396	CbGpPWpGaD
Zolpidem—GABRA2—brainstem—brain cancer	0.000728	0.0206	CbGeAlD
Zolpidem—GABRB2—telencephalon—brain cancer	0.000707	0.02	CbGeAlD
Zolpidem—GABRG2—telencephalon—brain cancer	0.000707	0.02	CbGeAlD
Zolpidem—GABRA1—brainstem—brain cancer	0.000704	0.0199	CbGeAlD
Zolpidem—PTGS1—blood vessel—brain cancer	0.000686	0.0194	CbGeAlD
Zolpidem—CYP3A7—endocrine gland—brain cancer	0.000664	0.0188	CbGeAlD
Zolpidem—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000664	0.0361	CbGpPWpGaD
Zolpidem—GABRA2—telencephalon—brain cancer	0.000646	0.0183	CbGeAlD
Zolpidem—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000627	0.0341	CbGpPWpGaD
Zolpidem—GABRA1—telencephalon—brain cancer	0.000624	0.0177	CbGeAlD
Zolpidem—GABRG2—pituitary gland—brain cancer	0.000576	0.0163	CbGeAlD
Zolpidem—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000568	0.0309	CbGpPWpGaD
Zolpidem—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000565	0.0307	CbGpPWpGaD
Zolpidem—GABRG2—medulla oblongata—brain cancer	0.000556	0.0157	CbGeAlD
Zolpidem—GABRB2—medulla oblongata—brain cancer	0.000556	0.0157	CbGeAlD
Zolpidem—GABRA3—endocrine gland—brain cancer	0.000547	0.0155	CbGeAlD
Zolpidem—GABRB3—telencephalon—brain cancer	0.000543	0.0154	CbGeAlD
Zolpidem—GABRA3—head—brain cancer	0.00054	0.0153	CbGeAlD
Zolpidem—CYP2D6—hindbrain—brain cancer	0.000538	0.0152	CbGeAlD
Zolpidem—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00053	0.0288	CbGpPWpGaD
Zolpidem—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00052	0.0283	CbGpPWpGaD
Zolpidem—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000517	0.0281	CbGpPWpGaD
Zolpidem—GABRG2—midbrain—brain cancer	0.000508	0.0144	CbGeAlD
Zolpidem—GABRB2—midbrain—brain cancer	0.000508	0.0144	CbGeAlD
Zolpidem—GABRG2—spinal cord—brain cancer	0.000496	0.014	CbGeAlD
Zolpidem—GABRB2—spinal cord—brain cancer	0.000496	0.014	CbGeAlD
Zolpidem—GABRA3—central nervous system—brain cancer	0.000493	0.0139	CbGeAlD
Zolpidem—GABRA1—medulla oblongata—brain cancer	0.000491	0.0139	CbGeAlD
Zolpidem—GABRB3—gonad—brain cancer	0.000453	0.0128	CbGeAlD
Zolpidem—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000453	0.0246	CbGpPWpGaD
Zolpidem—GABRA1—midbrain—brain cancer	0.000448	0.0127	CbGeAlD
Zolpidem—GABRB3—pituitary gland—brain cancer	0.000442	0.0125	CbGeAlD
Zolpidem—GABRG2—head—brain cancer	0.00044	0.0125	CbGeAlD
Zolpidem—GABRB2—head—brain cancer	0.00044	0.0125	CbGeAlD
Zolpidem—GABRA1—spinal cord—brain cancer	0.000438	0.0124	CbGeAlD
Zolpidem—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000436	0.0237	CbGpPWpGaD
Zolpidem—GABRB3—medulla oblongata—brain cancer	0.000427	0.0121	CbGeAlD
Zolpidem—GABRA2—head—brain cancer	0.000402	0.0114	CbGeAlD
Zolpidem—GABRG2—central nervous system—brain cancer	0.000402	0.0114	CbGeAlD
Zolpidem—GABRB2—central nervous system—brain cancer	0.000402	0.0114	CbGeAlD
Zolpidem—GABRG2—cerebellum—brain cancer	0.000393	0.0111	CbGeAlD
Zolpidem—GABRB2—cerebellum—brain cancer	0.000393	0.0111	CbGeAlD
Zolpidem—GABRA3—brain—brain cancer	0.000391	0.0111	CbGeAlD
Zolpidem—GABRB3—midbrain—brain cancer	0.00039	0.011	CbGeAlD
Zolpidem—GABRA1—head—brain cancer	0.000389	0.011	CbGeAlD
Zolpidem—GABRB3—spinal cord—brain cancer	0.000381	0.0108	CbGeAlD
Zolpidem—GABRA2—central nervous system—brain cancer	0.000367	0.0104	CbGeAlD
Zolpidem—GABRA2—cerebellum—brain cancer	0.000359	0.0101	CbGeAlD
Zolpidem—GABRA1—central nervous system—brain cancer	0.000355	0.01	CbGeAlD
Zolpidem—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00035	0.019	CbGpPWpGaD
Zolpidem—GABRA1—cerebellum—brain cancer	0.000347	0.00981	CbGeAlD
Zolpidem—GABRB3—endocrine gland—brain cancer	0.000343	0.00969	CbGeAlD
Zolpidem—GABRB3—head—brain cancer	0.000338	0.00956	CbGeAlD
Zolpidem—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000337	0.0183	CbGpPWpGaD
Zolpidem—PTGS1—telencephalon—brain cancer	0.000333	0.00941	CbGeAlD
Zolpidem—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000322	0.0175	CbGpPWpGaD
Zolpidem—GABRB2—brain—brain cancer	0.000319	0.00902	CbGeAlD
Zolpidem—GABRG2—brain—brain cancer	0.000319	0.00902	CbGeAlD
Zolpidem—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000311	0.0169	CbGpPWpGaD
Zolpidem—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00031	0.0168	CbGpPWpGaD
Zolpidem—GABRB3—central nervous system—brain cancer	0.000309	0.00873	CbGeAlD
Zolpidem—CYP2D6—brainstem—brain cancer	0.000308	0.00872	CbGeAlD
Zolpidem—GABRB3—cerebellum—brain cancer	0.000302	0.00853	CbGeAlD
Zolpidem—CYP2C19—endocrine gland—brain cancer	0.000297	0.00839	CbGeAlD
Zolpidem—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000292	0.0159	CbGpPWpGaD
Zolpidem—GABRA2—brain—brain cancer	0.000292	0.00824	CbGeAlD
Zolpidem—Stomatitis—Carmustine—brain cancer	0.000283	0.00199	CcSEcCtD
Zolpidem—Urinary tract infection—Carmustine—brain cancer	0.000282	0.00198	CcSEcCtD
Zolpidem—Pneumonia—Temozolomide—brain cancer	0.000282	0.00198	CcSEcCtD
Zolpidem—Anorexia—Procarbazine—brain cancer	0.000282	0.00198	CcSEcCtD
Zolpidem—GABRA1—brain—brain cancer	0.000282	0.00797	CbGeAlD
Zolpidem—Erythema—Hydroxyurea—brain cancer	0.000281	0.00197	CcSEcCtD
Zolpidem—Infestation NOS—Temozolomide—brain cancer	0.000281	0.00197	CcSEcCtD
Zolpidem—Infestation—Temozolomide—brain cancer	0.000281	0.00197	CcSEcCtD
Zolpidem—Depression—Temozolomide—brain cancer	0.00028	0.00197	CcSEcCtD
Zolpidem—Nausea—Lomustine—brain cancer	0.000277	0.00195	CcSEcCtD
Zolpidem—Hypotension—Procarbazine—brain cancer	0.000277	0.00194	CcSEcCtD
Zolpidem—GABRB2—Orphan transporters—S100A10—brain cancer	0.000275	0.015	CbGpPWpGaD
Zolpidem—Neuropathy peripheral—Temozolomide—brain cancer	0.000275	0.00193	CcSEcCtD
Zolpidem—CYP2D6—telencephalon—brain cancer	0.000274	0.00774	CbGeAlD
Zolpidem—Stomatitis—Temozolomide—brain cancer	0.000274	0.00192	CcSEcCtD
Zolpidem—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000273	0.0148	CbGpPWpGaD
Zolpidem—Urinary tract infection—Temozolomide—brain cancer	0.000273	0.00192	CcSEcCtD
Zolpidem—PTGS1—pituitary gland—brain cancer	0.000271	0.00766	CbGeAlD
Zolpidem—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00027	0.00189	CcSEcCtD
Zolpidem—Insomnia—Procarbazine—brain cancer	0.000268	0.00188	CcSEcCtD
Zolpidem—Paraesthesia—Procarbazine—brain cancer	0.000266	0.00187	CcSEcCtD
Zolpidem—Sinusitis—Temozolomide—brain cancer	0.000263	0.00185	CcSEcCtD
Zolpidem—Somnolence—Procarbazine—brain cancer	0.000263	0.00185	CcSEcCtD
Zolpidem—GABRA3—Orphan transporters—S100A10—brain cancer	0.000263	0.0143	CbGpPWpGaD
Zolpidem—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000263	0.0143	CbGpPWpGaD
Zolpidem—Cramp muscle—Etoposide—brain cancer	0.000262	0.00184	CcSEcCtD
Zolpidem—Ill-defined disorder—Hydroxyurea—brain cancer	0.00026	0.00183	CcSEcCtD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00026	0.0142	CbGpPWpGaD
Zolpidem—Anaemia—Hydroxyurea—brain cancer	0.000259	0.00182	CcSEcCtD
Zolpidem—Hallucination—Carmustine—brain cancer	0.000259	0.00182	CcSEcCtD
Zolpidem—Hypoaesthesia—Carmustine—brain cancer	0.000259	0.00182	CcSEcCtD
Zolpidem—GABRA2—Orphan transporters—S100A10—brain cancer	0.000258	0.014	CbGpPWpGaD
Zolpidem—Decreased appetite—Procarbazine—brain cancer	0.000257	0.00181	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Etoposide—brain cancer	0.000257	0.00181	CcSEcCtD
Zolpidem—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000257	0.014	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—S100A10—brain cancer	0.000256	0.0139	CbGpPWpGaD
Zolpidem—Connective tissue disorder—Carmustine—brain cancer	0.000256	0.0018	CcSEcCtD
Zolpidem—Fatigue—Procarbazine—brain cancer	0.000255	0.00179	CcSEcCtD
Zolpidem—Malaise—Hydroxyurea—brain cancer	0.000253	0.00178	CcSEcCtD
Zolpidem—Constipation—Procarbazine—brain cancer	0.000253	0.00178	CcSEcCtD
Zolpidem—Pain—Procarbazine—brain cancer	0.000253	0.00178	CcSEcCtD
Zolpidem—Dysphagia—Etoposide—brain cancer	0.000252	0.00177	CcSEcCtD
Zolpidem—GABRG2—Orphan transporters—S100A10—brain cancer	0.000252	0.0137	CbGpPWpGaD
Zolpidem—Leukopenia—Hydroxyurea—brain cancer	0.000251	0.00177	CcSEcCtD
Zolpidem—Visual impairment—Carmustine—brain cancer	0.000251	0.00176	CcSEcCtD
Zolpidem—Hallucination—Temozolomide—brain cancer	0.000251	0.00176	CcSEcCtD
Zolpidem—Hypoaesthesia—Temozolomide—brain cancer	0.000251	0.00176	CcSEcCtD
Zolpidem—Pharyngitis—Temozolomide—brain cancer	0.00025	0.00176	CcSEcCtD
Zolpidem—Urinary tract disorder—Temozolomide—brain cancer	0.000249	0.00175	CcSEcCtD
Zolpidem—Bronchospasm—Etoposide—brain cancer	0.000248	0.00174	CcSEcCtD
Zolpidem—Connective tissue disorder—Temozolomide—brain cancer	0.000248	0.00174	CcSEcCtD
Zolpidem—Urethral disorder—Temozolomide—brain cancer	0.000247	0.00173	CcSEcCtD
Zolpidem—Sweating increased—Etoposide—brain cancer	0.000245	0.00172	CcSEcCtD
Zolpidem—GABRB3—brain—brain cancer	0.000245	0.00693	CbGeAlD
Zolpidem—Feeling abnormal—Procarbazine—brain cancer	0.000244	0.00171	CcSEcCtD
Zolpidem—Eye disorder—Carmustine—brain cancer	0.000244	0.00171	CcSEcCtD
Zolpidem—Visual impairment—Temozolomide—brain cancer	0.000243	0.00171	CcSEcCtD
Zolpidem—CYP1A2—endocrine gland—brain cancer	0.000242	0.00685	CbGeAlD
Zolpidem—Gastrointestinal pain—Procarbazine—brain cancer	0.000242	0.0017	CcSEcCtD
Zolpidem—Flushing—Carmustine—brain cancer	0.000242	0.0017	CcSEcCtD
Zolpidem—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000241	0.0131	CbGpPWpGaD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000237	0.00167	CcSEcCtD
Zolpidem—Discomfort—Hydroxyurea—brain cancer	0.000236	0.00166	CcSEcCtD
Zolpidem—Eye disorder—Temozolomide—brain cancer	0.000235	0.00165	CcSEcCtD
Zolpidem—Urticaria—Procarbazine—brain cancer	0.000235	0.00165	CcSEcCtD
Zolpidem—Tinnitus—Temozolomide—brain cancer	0.000235	0.00165	CcSEcCtD
Zolpidem—Abdominal pain—Procarbazine—brain cancer	0.000234	0.00164	CcSEcCtD
Zolpidem—Body temperature increased—Procarbazine—brain cancer	0.000234	0.00164	CcSEcCtD
Zolpidem—Cardiac disorder—Temozolomide—brain cancer	0.000234	0.00164	CcSEcCtD
Zolpidem—Flushing—Temozolomide—brain cancer	0.000234	0.00164	CcSEcCtD
Zolpidem—CYP3A5—endocrine gland—brain cancer	0.000234	0.00661	CbGeAlD
Zolpidem—PTGS1—spinal cord—brain cancer	0.000233	0.00659	CbGeAlD
Zolpidem—Arrhythmia—Carmustine—brain cancer	0.000233	0.00164	CcSEcCtD
Zolpidem—CYP2C9—endocrine gland—brain cancer	0.00023	0.0065	CbGeAlD
Zolpidem—Oedema—Hydroxyurea—brain cancer	0.000229	0.00161	CcSEcCtD
Zolpidem—Mental disorder—Carmustine—brain cancer	0.000228	0.0016	CcSEcCtD
Zolpidem—Infection—Hydroxyurea—brain cancer	0.000228	0.0016	CcSEcCtD
Zolpidem—Mediastinal disorder—Temozolomide—brain cancer	0.000227	0.00159	CcSEcCtD
Zolpidem—Erythema—Carmustine—brain cancer	0.000227	0.00159	CcSEcCtD
Zolpidem—Malnutrition—Carmustine—brain cancer	0.000227	0.00159	CcSEcCtD
Zolpidem—Chills—Temozolomide—brain cancer	0.000226	0.00159	CcSEcCtD
Zolpidem—Pneumonia—Etoposide—brain cancer	0.000226	0.00159	CcSEcCtD
Zolpidem—Nervous system disorder—Hydroxyurea—brain cancer	0.000225	0.00158	CcSEcCtD
Zolpidem—Infestation NOS—Etoposide—brain cancer	0.000225	0.00158	CcSEcCtD
Zolpidem—Infestation—Etoposide—brain cancer	0.000225	0.00158	CcSEcCtD
Zolpidem—Skin disorder—Hydroxyurea—brain cancer	0.000223	0.00156	CcSEcCtD
Zolpidem—Acute coronary syndrome—Etoposide—brain cancer	0.000221	0.00155	CcSEcCtD
Zolpidem—Mental disorder—Temozolomide—brain cancer	0.000221	0.00155	CcSEcCtD
Zolpidem—Neuropathy peripheral—Etoposide—brain cancer	0.00022	0.00155	CcSEcCtD
Zolpidem—Myocardial infarction—Etoposide—brain cancer	0.00022	0.00155	CcSEcCtD
Zolpidem—GABRA1—Orphan transporters—S100A10—brain cancer	0.00022	0.012	CbGpPWpGaD
Zolpidem—Back pain—Carmustine—brain cancer	0.00022	0.00154	CcSEcCtD
Zolpidem—Erythema—Temozolomide—brain cancer	0.000219	0.00154	CcSEcCtD
Zolpidem—Malnutrition—Temozolomide—brain cancer	0.000219	0.00154	CcSEcCtD
Zolpidem—Stomatitis—Etoposide—brain cancer	0.000219	0.00154	CcSEcCtD
Zolpidem—Anorexia—Hydroxyurea—brain cancer	0.000218	0.00153	CcSEcCtD
Zolpidem—Hypersensitivity—Procarbazine—brain cancer	0.000218	0.00153	CcSEcCtD
Zolpidem—Dysgeusia—Temozolomide—brain cancer	0.000215	0.00151	CcSEcCtD
Zolpidem—Vision blurred—Carmustine—brain cancer	0.000214	0.0015	CcSEcCtD
Zolpidem—Tremor—Carmustine—brain cancer	0.000213	0.00149	CcSEcCtD
Zolpidem—Asthenia—Procarbazine—brain cancer	0.000212	0.00149	CcSEcCtD
Zolpidem—Back pain—Temozolomide—brain cancer	0.000212	0.00149	CcSEcCtD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000211	0.0115	CbGpPWpGaD
Zolpidem—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000211	0.0115	CbGpPWpGaD
Zolpidem—PTGS1—endocrine gland—brain cancer	0.00021	0.00594	CbGeAlD
Zolpidem—Anaemia—Carmustine—brain cancer	0.00021	0.00147	CcSEcCtD
Zolpidem—Pruritus—Procarbazine—brain cancer	0.000209	0.00147	CcSEcCtD
Zolpidem—Agitation—Carmustine—brain cancer	0.000209	0.00146	CcSEcCtD
Zolpidem—PTGS1—head—brain cancer	0.000207	0.00586	CbGeAlD
Zolpidem—Vision blurred—Temozolomide—brain cancer	0.000207	0.00145	CcSEcCtD
Zolpidem—Tremor—Temozolomide—brain cancer	0.000205	0.00144	CcSEcCtD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000205	0.0111	CbGpPWpGaD
Zolpidem—Dyspnoea—Hydroxyurea—brain cancer	0.000204	0.00143	CcSEcCtD
Zolpidem—Somnolence—Hydroxyurea—brain cancer	0.000204	0.00143	CcSEcCtD
Zolpidem—Ill-defined disorder—Temozolomide—brain cancer	0.000203	0.00143	CcSEcCtD
Zolpidem—Leukopenia—Carmustine—brain cancer	0.000203	0.00143	CcSEcCtD
Zolpidem—Anaemia—Temozolomide—brain cancer	0.000203	0.00142	CcSEcCtD
Zolpidem—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000203	0.011	CbGpPWpGaD
Zolpidem—Diarrhoea—Procarbazine—brain cancer	0.000203	0.00142	CcSEcCtD
Zolpidem—Dyspepsia—Hydroxyurea—brain cancer	0.000202	0.00142	CcSEcCtD
Zolpidem—Agitation—Temozolomide—brain cancer	0.000202	0.00142	CcSEcCtD
Zolpidem—Hypoaesthesia—Etoposide—brain cancer	0.000201	0.00141	CcSEcCtD
Zolpidem—Angioedema—Temozolomide—brain cancer	0.0002	0.00141	CcSEcCtD
Zolpidem—Decreased appetite—Hydroxyurea—brain cancer	0.000199	0.0014	CcSEcCtD
Zolpidem—Urinary tract disorder—Etoposide—brain cancer	0.000199	0.0014	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000198	0.00139	CcSEcCtD
Zolpidem—Malaise—Temozolomide—brain cancer	0.000198	0.00139	CcSEcCtD
Zolpidem—Urethral disorder—Etoposide—brain cancer	0.000198	0.00139	CcSEcCtD
Zolpidem—Fatigue—Hydroxyurea—brain cancer	0.000198	0.00139	CcSEcCtD
Zolpidem—Vertigo—Temozolomide—brain cancer	0.000197	0.00138	CcSEcCtD
Zolpidem—Leukopenia—Temozolomide—brain cancer	0.000196	0.00138	CcSEcCtD
Zolpidem—Hypertension—Carmustine—brain cancer	0.000196	0.00138	CcSEcCtD
Zolpidem—Pain—Hydroxyurea—brain cancer	0.000196	0.00138	CcSEcCtD
Zolpidem—Constipation—Hydroxyurea—brain cancer	0.000196	0.00138	CcSEcCtD
Zolpidem—Dizziness—Procarbazine—brain cancer	0.000196	0.00138	CcSEcCtD
Zolpidem—Palpitations—Temozolomide—brain cancer	0.000194	0.00136	CcSEcCtD
Zolpidem—Chest pain—Carmustine—brain cancer	0.000193	0.00136	CcSEcCtD
Zolpidem—Myalgia—Carmustine—brain cancer	0.000193	0.00136	CcSEcCtD
Zolpidem—Anxiety—Carmustine—brain cancer	0.000193	0.00135	CcSEcCtD
Zolpidem—Cough—Temozolomide—brain cancer	0.000191	0.00134	CcSEcCtD
Zolpidem—Hypertension—Temozolomide—brain cancer	0.000189	0.00133	CcSEcCtD
Zolpidem—PTGS1—central nervous system—brain cancer	0.000189	0.00535	CbGeAlD
Zolpidem—Feeling abnormal—Hydroxyurea—brain cancer	0.000189	0.00133	CcSEcCtD
Zolpidem—Eye disorder—Etoposide—brain cancer	0.000188	0.00132	CcSEcCtD
Zolpidem—Vomiting—Procarbazine—brain cancer	0.000188	0.00132	CcSEcCtD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000188	0.0102	CbGpPWpGaD
Zolpidem—Cardiac disorder—Etoposide—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Flushing—Etoposide—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Confusional state—Carmustine—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Arthralgia—Temozolomide—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Myalgia—Temozolomide—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Rash—Procarbazine—brain cancer	0.000187	0.00131	CcSEcCtD
Zolpidem—Dermatitis—Procarbazine—brain cancer	0.000186	0.00131	CcSEcCtD
Zolpidem—Anxiety—Temozolomide—brain cancer	0.000186	0.00131	CcSEcCtD
Zolpidem—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000186	0.0101	CbGpPWpGaD
Zolpidem—Headache—Procarbazine—brain cancer	0.000185	0.0013	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000185	0.0013	CcSEcCtD
Zolpidem—Oedema—Carmustine—brain cancer	0.000185	0.0013	CcSEcCtD
Zolpidem—Discomfort—Temozolomide—brain cancer	0.000184	0.0013	CcSEcCtD
Zolpidem—Infection—Carmustine—brain cancer	0.000184	0.00129	CcSEcCtD
Zolpidem—GABRB3—BDNF signaling pathway—NTRK3—brain cancer	0.000184	0.00999	CbGpPWpGaD
Zolpidem—Dry mouth—Temozolomide—brain cancer	0.000183	0.00128	CcSEcCtD
Zolpidem—Mediastinal disorder—Etoposide—brain cancer	0.000182	0.00128	CcSEcCtD
Zolpidem—Body temperature increased—Hydroxyurea—brain cancer	0.000181	0.00127	CcSEcCtD
Zolpidem—Chills—Etoposide—brain cancer	0.000181	0.00127	CcSEcCtD
Zolpidem—Tachycardia—Carmustine—brain cancer	0.000181	0.00127	CcSEcCtD
Zolpidem—Confusional state—Temozolomide—brain cancer	0.00018	0.00127	CcSEcCtD
Zolpidem—Oedema—Temozolomide—brain cancer	0.000179	0.00126	CcSEcCtD
Zolpidem—Anaphylactic shock—Temozolomide—brain cancer	0.000179	0.00126	CcSEcCtD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000179	0.00971	CbGpPWpGaD
Zolpidem—Infection—Temozolomide—brain cancer	0.000178	0.00125	CcSEcCtD
Zolpidem—Anorexia—Carmustine—brain cancer	0.000177	0.00124	CcSEcCtD
Zolpidem—Nausea—Procarbazine—brain cancer	0.000176	0.00124	CcSEcCtD
Zolpidem—Nervous system disorder—Temozolomide—brain cancer	0.000176	0.00123	CcSEcCtD
Zolpidem—CYP3A4—endocrine gland—brain cancer	0.000175	0.00496	CbGeAlD
Zolpidem—Skin disorder—Temozolomide—brain cancer	0.000174	0.00122	CcSEcCtD
Zolpidem—Hypotension—Carmustine—brain cancer	0.000173	0.00122	CcSEcCtD
Zolpidem—Hyperhidrosis—Temozolomide—brain cancer	0.000173	0.00122	CcSEcCtD
Zolpidem—CYP2D6—endocrine gland—brain cancer	0.000173	0.00488	CbGeAlD
Zolpidem—Dysgeusia—Etoposide—brain cancer	0.000172	0.00121	CcSEcCtD
Zolpidem—Anorexia—Temozolomide—brain cancer	0.000171	0.0012	CcSEcCtD
Zolpidem—CYP2D6—head—brain cancer	0.00017	0.00482	CbGeAlD
Zolpidem—Back pain—Etoposide—brain cancer	0.00017	0.00119	CcSEcCtD
Zolpidem—Hypersensitivity—Hydroxyurea—brain cancer	0.000169	0.00119	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Carmustine—brain cancer	0.000169	0.00119	CcSEcCtD
Zolpidem—Muscle spasms—Etoposide—brain cancer	0.000169	0.00119	CcSEcCtD
Zolpidem—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000168	0.00915	CbGpPWpGaD
Zolpidem—Insomnia—Carmustine—brain cancer	0.000168	0.00118	CcSEcCtD
Zolpidem—Paraesthesia—Carmustine—brain cancer	0.000166	0.00117	CcSEcCtD
Zolpidem—Dyspnoea—Carmustine—brain cancer	0.000165	0.00116	CcSEcCtD
Zolpidem—Somnolence—Carmustine—brain cancer	0.000165	0.00116	CcSEcCtD
Zolpidem—Asthenia—Hydroxyurea—brain cancer	0.000164	0.00115	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000163	0.00115	CcSEcCtD
Zolpidem—Ill-defined disorder—Etoposide—brain cancer	0.000163	0.00114	CcSEcCtD
Zolpidem—Anaemia—Etoposide—brain cancer	0.000162	0.00114	CcSEcCtD
Zolpidem—Insomnia—Temozolomide—brain cancer	0.000162	0.00114	CcSEcCtD
Zolpidem—Decreased appetite—Carmustine—brain cancer	0.000161	0.00113	CcSEcCtD
Zolpidem—Paraesthesia—Temozolomide—brain cancer	0.000161	0.00113	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Carmustine—brain cancer	0.00016	0.00112	CcSEcCtD
Zolpidem—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00016	0.00869	CbGpPWpGaD
Zolpidem—Dyspnoea—Temozolomide—brain cancer	0.00016	0.00112	CcSEcCtD
Zolpidem—Somnolence—Temozolomide—brain cancer	0.000159	0.00112	CcSEcCtD
Zolpidem—Constipation—Carmustine—brain cancer	0.000158	0.00111	CcSEcCtD
Zolpidem—Pain—Carmustine—brain cancer	0.000158	0.00111	CcSEcCtD
Zolpidem—Malaise—Etoposide—brain cancer	0.000158	0.00111	CcSEcCtD
Zolpidem—CYP3A4—central nervous system—brain cancer	0.000158	0.00447	CbGeAlD
Zolpidem—Vertigo—Etoposide—brain cancer	0.000158	0.00111	CcSEcCtD
Zolpidem—Dyspepsia—Temozolomide—brain cancer	0.000158	0.00111	CcSEcCtD
Zolpidem—Leukopenia—Etoposide—brain cancer	0.000157	0.0011	CcSEcCtD
Zolpidem—Diarrhoea—Hydroxyurea—brain cancer	0.000157	0.0011	CcSEcCtD
Zolpidem—Decreased appetite—Temozolomide—brain cancer	0.000156	0.00109	CcSEcCtD
Zolpidem—CYP2D6—central nervous system—brain cancer	0.000156	0.0044	CbGeAlD
Zolpidem—Gastrointestinal disorder—Temozolomide—brain cancer	0.000155	0.00109	CcSEcCtD
Zolpidem—Fatigue—Temozolomide—brain cancer	0.000154	0.00108	CcSEcCtD
Zolpidem—Loss of consciousness—Etoposide—brain cancer	0.000154	0.00108	CcSEcCtD
Zolpidem—Cough—Etoposide—brain cancer	0.000153	0.00108	CcSEcCtD
Zolpidem—Constipation—Temozolomide—brain cancer	0.000153	0.00108	CcSEcCtD
Zolpidem—Pain—Temozolomide—brain cancer	0.000153	0.00108	CcSEcCtD
Zolpidem—Feeling abnormal—Carmustine—brain cancer	0.000153	0.00107	CcSEcCtD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000153	0.00829	CbGpPWpGaD
Zolpidem—CYP2D6—cerebellum—brain cancer	0.000152	0.0043	CbGeAlD
Zolpidem—Hypertension—Etoposide—brain cancer	0.000152	0.00106	CcSEcCtD
Zolpidem—Dizziness—Hydroxyurea—brain cancer	0.000152	0.00106	CcSEcCtD
Zolpidem—Gastrointestinal pain—Carmustine—brain cancer	0.000151	0.00106	CcSEcCtD
Zolpidem—PTGS1—brain—brain cancer	0.00015	0.00425	CbGeAlD
Zolpidem—Chest pain—Etoposide—brain cancer	0.000149	0.00105	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000148	0.00104	CcSEcCtD
Zolpidem—Discomfort—Etoposide—brain cancer	0.000148	0.00104	CcSEcCtD
Zolpidem—Feeling abnormal—Temozolomide—brain cancer	0.000147	0.00104	CcSEcCtD
Zolpidem—Abdominal pain—Carmustine—brain cancer	0.000146	0.00103	CcSEcCtD
Zolpidem—Body temperature increased—Carmustine—brain cancer	0.000146	0.00103	CcSEcCtD
Zolpidem—Gastrointestinal pain—Temozolomide—brain cancer	0.000146	0.00103	CcSEcCtD
Zolpidem—Vomiting—Hydroxyurea—brain cancer	0.000146	0.00102	CcSEcCtD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000145	0.00791	CbGpPWpGaD
Zolpidem—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000145	0.00786	CbGpPWpGaD
Zolpidem—Rash—Hydroxyurea—brain cancer	0.000144	0.00101	CcSEcCtD
Zolpidem—Confusional state—Etoposide—brain cancer	0.000144	0.00101	CcSEcCtD
Zolpidem—Dermatitis—Hydroxyurea—brain cancer	0.000144	0.00101	CcSEcCtD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000144	0.00781	CbGpPWpGaD
Zolpidem—Headache—Hydroxyurea—brain cancer	0.000144	0.00101	CcSEcCtD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000143	0.00779	CbGpPWpGaD
Zolpidem—Anaphylactic shock—Etoposide—brain cancer	0.000143	0.00101	CcSEcCtD
Zolpidem—Infection—Etoposide—brain cancer	0.000142	0.000999	CcSEcCtD
Zolpidem—Urticaria—Temozolomide—brain cancer	0.000142	0.000999	CcSEcCtD
Zolpidem—Abdominal pain—Temozolomide—brain cancer	0.000141	0.000994	CcSEcCtD
Zolpidem—Body temperature increased—Temozolomide—brain cancer	0.000141	0.000994	CcSEcCtD
Zolpidem—Tachycardia—Etoposide—brain cancer	0.00014	0.000982	CcSEcCtD
Zolpidem—Skin disorder—Etoposide—brain cancer	0.000139	0.000977	CcSEcCtD
Zolpidem—Hyperhidrosis—Etoposide—brain cancer	0.000138	0.000973	CcSEcCtD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000138	0.00749	CbGpPWpGaD
Zolpidem—Anorexia—Etoposide—brain cancer	0.000137	0.000959	CcSEcCtD
Zolpidem—Hypersensitivity—Carmustine—brain cancer	0.000136	0.000959	CcSEcCtD
Zolpidem—Nausea—Hydroxyurea—brain cancer	0.000136	0.000956	CcSEcCtD
Zolpidem—Hypotension—Etoposide—brain cancer	0.000134	0.00094	CcSEcCtD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.00727	CbGpPWpGaD
Zolpidem—Asthenia—Carmustine—brain cancer	0.000133	0.000933	CcSEcCtD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000132	0.00718	CbGpPWpGaD
Zolpidem—Hypersensitivity—Temozolomide—brain cancer	0.000132	0.000926	CcSEcCtD
Zolpidem—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000131	0.00713	CbGpPWpGaD
Zolpidem—Paraesthesia—Etoposide—brain cancer	0.000129	0.000903	CcSEcCtD
Zolpidem—Asthenia—Temozolomide—brain cancer	0.000128	0.000902	CcSEcCtD
Zolpidem—Dyspnoea—Etoposide—brain cancer	0.000128	0.000897	CcSEcCtD
Zolpidem—Somnolence—Etoposide—brain cancer	0.000127	0.000894	CcSEcCtD
Zolpidem—Diarrhoea—Carmustine—brain cancer	0.000127	0.00089	CcSEcCtD
Zolpidem—Pruritus—Temozolomide—brain cancer	0.000127	0.000889	CcSEcCtD
Zolpidem—Decreased appetite—Etoposide—brain cancer	0.000125	0.000875	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Etoposide—brain cancer	0.000124	0.000869	CcSEcCtD
Zolpidem—Fatigue—Etoposide—brain cancer	0.000123	0.000867	CcSEcCtD
Zolpidem—CYP2D6—brain—brain cancer	0.000123	0.00349	CbGeAlD
Zolpidem—Dizziness—Carmustine—brain cancer	0.000122	0.00086	CcSEcCtD
Zolpidem—Pain—Etoposide—brain cancer	0.000122	0.00086	CcSEcCtD
Zolpidem—Constipation—Etoposide—brain cancer	0.000122	0.00086	CcSEcCtD
Zolpidem—Diarrhoea—Temozolomide—brain cancer	0.000122	0.00086	CcSEcCtD
Zolpidem—Dizziness—Temozolomide—brain cancer	0.000118	0.000831	CcSEcCtD
Zolpidem—Feeling abnormal—Etoposide—brain cancer	0.000118	0.000829	CcSEcCtD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000118	0.00641	CbGpPWpGaD
Zolpidem—Vomiting—Carmustine—brain cancer	0.000118	0.000827	CcSEcCtD
Zolpidem—Gastrointestinal pain—Etoposide—brain cancer	0.000117	0.000823	CcSEcCtD
Zolpidem—Rash—Carmustine—brain cancer	0.000117	0.00082	CcSEcCtD
Zolpidem—Dermatitis—Carmustine—brain cancer	0.000117	0.00082	CcSEcCtD
Zolpidem—Headache—Carmustine—brain cancer	0.000116	0.000815	CcSEcCtD
Zolpidem—Vomiting—Temozolomide—brain cancer	0.000114	0.000799	CcSEcCtD
Zolpidem—Urticaria—Etoposide—brain cancer	0.000114	0.000799	CcSEcCtD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000113	0.00616	CbGpPWpGaD
Zolpidem—Abdominal pain—Etoposide—brain cancer	0.000113	0.000795	CcSEcCtD
Zolpidem—Body temperature increased—Etoposide—brain cancer	0.000113	0.000795	CcSEcCtD
Zolpidem—Rash—Temozolomide—brain cancer	0.000113	0.000793	CcSEcCtD
Zolpidem—Dermatitis—Temozolomide—brain cancer	0.000113	0.000792	CcSEcCtD
Zolpidem—Headache—Temozolomide—brain cancer	0.000112	0.000788	CcSEcCtD
Zolpidem—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00609	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000112	0.00608	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000111	0.00601	CbGpPWpGaD
Zolpidem—Nausea—Carmustine—brain cancer	0.00011	0.000773	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000109	0.00591	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000108	0.0059	CbGpPWpGaD
Zolpidem—Nausea—Temozolomide—brain cancer	0.000106	0.000747	CcSEcCtD
Zolpidem—Hypersensitivity—Etoposide—brain cancer	0.000106	0.000741	CcSEcCtD
Zolpidem—Asthenia—Etoposide—brain cancer	0.000103	0.000722	CcSEcCtD
Zolpidem—Pruritus—Etoposide—brain cancer	0.000101	0.000712	CcSEcCtD
Zolpidem—Diarrhoea—Etoposide—brain cancer	9.8e-05	0.000688	CcSEcCtD
Zolpidem—Dizziness—Etoposide—brain cancer	9.47e-05	0.000665	CcSEcCtD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.19e-05	0.005	CbGpPWpGaD
Zolpidem—Vomiting—Etoposide—brain cancer	9.11e-05	0.00064	CcSEcCtD
Zolpidem—Rash—Etoposide—brain cancer	9.03e-05	0.000634	CcSEcCtD
Zolpidem—Dermatitis—Etoposide—brain cancer	9.02e-05	0.000634	CcSEcCtD
Zolpidem—Headache—Etoposide—brain cancer	8.97e-05	0.00063	CcSEcCtD
Zolpidem—GABRB2—Ion channel transport—TRPC6—brain cancer	8.92e-05	0.00485	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.75e-05	0.00476	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.63e-05	0.00469	CbGpPWpGaD
Zolpidem—Nausea—Etoposide—brain cancer	8.51e-05	0.000598	CcSEcCtD
Zolpidem—GABRA3—Ion channel transport—TRPC6—brain cancer	8.51e-05	0.00462	CbGpPWpGaD
Zolpidem—GABRA2—Ion channel transport—TRPC6—brain cancer	8.36e-05	0.00454	CbGpPWpGaD
Zolpidem—GABRB3—Ion channel transport—TRPC6—brain cancer	8.3e-05	0.00452	CbGpPWpGaD
Zolpidem—GABRG2—Ion channel transport—TRPC6—brain cancer	8.16e-05	0.00443	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP2C9—brain cancer	8.1e-05	0.00441	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	7.99e-05	0.00435	CbGpPWpGaD
Zolpidem—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.43e-05	0.00404	CbGpPWpGaD
Zolpidem—GABRA1—Ion channel transport—TRPC6—brain cancer	7.13e-05	0.00388	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.09e-05	0.00386	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	6.72e-05	0.00365	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	6.66e-05	0.00362	CbGpPWpGaD
Zolpidem—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.59e-05	0.00358	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	6.41e-05	0.00349	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	6.3e-05	0.00343	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.27e-05	0.00341	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	6.26e-05	0.0034	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.18e-05	0.00336	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.15e-05	0.00334	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	6.1e-05	0.00331	CbGpPWpGaD
Zolpidem—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	6.05e-05	0.00329	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP2C9—brain cancer	5.76e-05	0.00313	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	5.68e-05	0.00309	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—SPP1—brain cancer	5.44e-05	0.00296	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	5.37e-05	0.00292	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.04e-05	0.00274	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—IRS2—brain cancer	4.92e-05	0.00267	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP2C9—brain cancer	4.88e-05	0.00265	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	4.81e-05	0.00262	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	4.73e-05	0.00257	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—APC—brain cancer	4.34e-05	0.00236	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.17e-05	0.00227	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	3.85e-05	0.00209	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.77e-05	0.00205	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.72e-05	0.00202	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—RELA—brain cancer	3.39e-05	0.00184	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.1e-05	0.00169	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.05e-05	0.00166	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.96e-05	0.00161	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	2.95e-05	0.0016	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.91e-05	0.00158	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	2.9e-05	0.00158	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.89e-05	0.00157	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.84e-05	0.00154	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.62e-05	0.00142	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—STAT3—brain cancer	2.57e-05	0.0014	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.48e-05	0.00135	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.41e-05	0.00131	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.37e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.22e-05	0.00121	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.09e-05	0.00114	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.05e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP2C9—brain cancer	1.92e-05	0.00104	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.87e-05	0.00102	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP2C9—brain cancer	1.86e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.76e-05	0.000956	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—BSG—brain cancer	1.63e-05	0.000886	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.6e-05	0.000872	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—BSG—brain cancer	1.58e-05	0.000859	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—IDH1—brain cancer	1.4e-05	0.000762	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP2C9—brain cancer	1.39e-05	0.000753	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.37e-05	0.000745	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—IDH1—brain cancer	1.36e-05	0.000739	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—BSG—brain cancer	1.18e-05	0.000641	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ENO2—brain cancer	1.11e-05	0.000602	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.11e-05	0.000601	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ENO2—brain cancer	1.07e-05	0.000584	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP2C9—brain cancer	1.07e-05	0.000582	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—IDH1—brain cancer	1.01e-05	0.000551	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP2C9—brain cancer	9.85e-06	0.000536	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—BSG—brain cancer	9.11e-06	0.000495	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—BSG—brain cancer	8.38e-06	0.000456	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP2C9—brain cancer	8.35e-06	0.000454	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—BSG—brain cancer	8.31e-06	0.000452	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ENO2—brain cancer	8.01e-06	0.000435	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—IDH1—brain cancer	7.83e-06	0.000426	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—IDH1—brain cancer	7.21e-06	0.000392	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—IDH1—brain cancer	7.14e-06	0.000388	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—BSG—brain cancer	7.1e-06	0.000386	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP2C9—brain cancer	6.44e-06	0.00035	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.38e-06	0.000347	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ENO2—brain cancer	6.19e-06	0.000337	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—IDH1—brain cancer	6.1e-06	0.000332	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.82e-06	0.000316	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ENO2—brain cancer	5.7e-06	0.00031	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ENO2—brain cancer	5.65e-06	0.000307	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—BSG—brain cancer	5.48e-06	0.000298	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CG—brain cancer	5.08e-06	0.000276	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.97e-06	0.00027	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CG—brain cancer	4.93e-06	0.000268	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ENO2—brain cancer	4.83e-06	0.000262	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—IDH1—brain cancer	4.71e-06	0.000256	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ENO2—brain cancer	3.72e-06	0.000202	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CG—brain cancer	3.67e-06	0.0002	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CG—brain cancer	2.84e-06	0.000154	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CG—brain cancer	2.61e-06	0.000142	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CG—brain cancer	2.59e-06	0.000141	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CG—brain cancer	2.21e-06	0.00012	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CG—brain cancer	1.71e-06	9.29e-05	CbGpPWpGaD
